50% OFF for Teachers’ Day!
Hamps Bio Limited
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Hamps Bio Limited was originally incorporated under the name 'Hamps Bio Private Limited' vide Certificate of Incorporation issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli on January 02, 2007. Subsequently, the Company status changed to Public Limited and the name of Company was changed to 'Hamps Bio Limited'. The fresh Certificate of Incorporation consequent to conversion was issued on July 12, 2023 by the Registrar of Companies, Ahmedabad, Gujarat.
The Company is engaged in the ethical marketing and distribution of pharma formulation products across wide range of dosage including tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as manufacturing of freeze dried and frozen products in the FMCG industry such as fruits, vegetables, herbs and flowers. The Company is recognized in pharma industry under the brand name 'Hamps' and in freeze-dried and frozen food division through own brand 'FzyEzy'.
The Company sell products through more than 50 distributor's network as on March 31, 2024 and E-commerce platform, including Amazon.com, Amazon.ca, Amazon.eu, Flipkart, Jio Mart, Etc. It sell pharma products primarily in 8 States and Union territories and FDFP products primarily in 4 countries and 22 States and Union territories.
In year 2007, the Company commenced operating as an ethical pharmaceutical marketing firm, with the network of its distributors in Gujarat region for distribution of pharmaceutical formulation products across therapeutic area's as well as consumer health care product. Further, it procure products with various contract manufacturers who has WHO GMP approved manufacturing plant facility. In 2017, the Company launched FMCG division, focusing in freeze dried and frozen products.
The Company is planning to raise money from public through IPO aggregating to Rs 6.5 Crore Equity Shares through Fresh Issue.
Hamps Bio Limited share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Hamps Bio Limited indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Hamps Bio Limited is valued compared to its competitors.
Hamps Bio Limited PE ratio helps investors understand what is the market value of each stock compared to Hamps Bio Limited's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Hamps Bio Limited evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Hamps Bio Limited generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Hamps Bio Limited in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Hamps Bio Limited shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Hamps Bio Limited compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Hamps Bio Limited over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Hamps Bio Limited helps investors get an insight into when they can enter or exit the stock. Key components of Hamps Bio Limited Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Hamps Bio Limited shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Hamps Bio Limited’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Hamps Bio Limited provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Hamps Bio Limited highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Hamps Bio Limited.
The balance sheet presents a snapshot of Hamps Bio Limited’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.